Nonprescription survey
This article was originally published in The Tan Sheet
Executive Summary
Ten percent of adults have taken one or more OTC products for a perceived cardiovascular health benefit, according to a survey published in the January American Journal of Preventive Medicine. Of those participants, 52.1% reported taking aspirin, 24.4% took vitamin E, 9.8% relied on garlic, and 3.8% took omega-3/fish oils/fatty acids, Margaret Artz, PhD, Department of Pharmaceutical Health Care & Health Systems, University of Minnesota, et al., report. Researchers used the 2000-2002 Minnesota Heart Survey to evaluate the vitamin, nonvitamin and OTC habits of 3,128 adults; at the time, vitamin E was the "dominant single-source vitamin" taken for CVH, though recent negative media reports have diminished the vitamin's reputation (1"The Tan Sheet" Nov. 15, 2004, p. 13). OTC product use was higher in participants over age 55 compared to younger age groups, the authors note. Almost one quarter (22%) of the 613 people using an Rx drug for CV reasons reported also taking OTC medications...
You may also be interested in...
Vitamin E Dose Increases Linked To Rise In Risk Of Death – Study
Negative results from a vitamin E study showing high doses of the supplement may lead to a greater risk of all-cause mortality increase industry anticipation of findings from ongoing prospective antioxidant trials
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.